CoChat

RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site

Open access
Haza, Katarzyna Z., Martin, Heather L., Rao, Ajinkya, Turner, Amy L., Saunders, Sophie E., Petersen, Britta, Tiede, Christian, Tipping, Kevin, Tang, Anna A., Ajayi, Modupe, Taylor, Thomas, Harvey, Maia, Fishwick, Keri M., Adams, Thomas L., Gaule, Thembaninkosi G., Trinh, Chi H., Johnson, Matthew, Breeze, Alexander L., Edwards, Thomas A., McPherson, Michael J., Tomlinson, Darren C. · 2021 · Nature Communications
Cited by 41

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

RAS mutations are the most common oncogenic drivers across human cancers, but there remains a paucity of clinically-validated pharmacological inhibitors of RAS, as druggable pockets have proven difficult to identify. Here, we identify two RAS-binding Affimer proteins, K3 and K6, that inhibit nucleotide exchange and downstream signaling pathways with distinct isoform and mutant profiles. Affimer K6 binds in the SI/SII pocket, whilst Affimer K3 is a non-covalent inhibitor of the SII region that reveals a conformer of wild-type RAS with a large, druggable SII/α3 pocket. Competitive NanoBRET between the RAS-binding Affimers and known RAS binding small-molecules demonstrates the potential to use Affimers as tools to identify pharmacophores. This work highlights the potential of using biologics with small interface surfaces to select unseen, druggable conformations in conjunction with pharmacophore identification for hard-to-drug proteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-24316-0

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 41

Metadata

Authors
Haza, K. Z., Martin, H. L., Rao, A., Turner, A. L., Saunders, S. E., Petersen, B., Tiede, C., Tipping, K., Tang, A. A., Ajayi, M., Taylor, T., Harvey, M., Fishwick, K. M., Adams, T. L., Gaule, T. G., Trinh, C. H., Johnson, M., Breeze, A. L., Edwards, T. A., McPherson, M. J., & Tomlinson, D. C.
Venue
Nature Communications
Published
2021-06-30
Volume
12
Issue
1
Pages
4045-4045
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3176664740
Cited by
41
References
16
FWCI
2.21
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site. https://app.cochat.ai/papers/10.1038/s41467-021-24316-0
The paper
Haza, K. Z., Martin, H. L., Rao, A., Turner, A. L., Saunders, S. E., Petersen, B., Tiede, C., Tipping, K., Tang, A. A., Ajayi, M., Taylor, T., Harvey, M., Fishwick, K. M., Adams, T. L., Gaule, T. G., Trinh, C. H., Johnson, M., Breeze, A. L., Edwards, T. A., . . . Tomlinson, D. C. (2021). RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site. Nature Communications. https://doi.org/10.1038/s41467-021-24316-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.